24 jul: Bobler fra dybet fik hammerslag på rekordpriser ved nyligt afhold..
01 aug: Mercedes CLS Shooting Brake på vej til Danmark
26-07-2012 11:57:00

UPDATE: Siemens Warns On Guidance; Shelves Osram IPO Plans

Relateret indhold

-Siemens shelves IPO plans for Osram, to spin off unit to shareholders instead

-Says difficult to reach EUR5.2 billion to EUR5.4 billion profit target due to economic challenges

-Warns demand from China won't pick up till 2013

(Adds details)

By Friedrich Geiger and Harriet Torry

MUNICH--German industrial conglomerate Siemens AG (SI) Thursday shelved plans to float its Osram lighting unit on the stock market and warned its full-year profit target is becoming more difficult to reach as third-quarter order intake fell sharply.

The company has been targeting profit of EUR5.2 billion to EUR5.4 billion for the year.

"We see growing reluctance among our customers regarding capital expenditures and stronger economic headwinds," said Chief Executive Peter Loescher.

The company's net profit, at 823 million euros ($996 million), was sharply below analysts' EUR1.32 billion consensus estimates due to an EUR351 million accounting charge related to a change in status of its lighting unit Osram which had been earmarked for an initial public offering.

Siemens warned demand from China is slowing and said it doesn't expect any recovery until next year. The company's focus now is on increasing productivity and efficiency as customers become more reluctant to spend. It said it will provide more details when it releases fourth-quarter results.

Siemens' guidance stands in contrast to that of industrial group ABB Ltd. (ABBN.VX), which on Thursday said it's more confident of its short-term outlook, and sees some signs of recovery in its China business.

"The macroeconomic view remains uncertain, but the positive developments we've seen in China, the continued strength of the U.S. market and our resilience in Europe make us more confident about the short-term outlook than we were three months ago,"said ABB Chief Executive Joe Hogan.

Developments are uneven, however, with another German heavyweight, chemicals group BASF SE (BAS.XE), Thursday noting slowing growth in China in the past quarter. BASF said it can't estimate when business in Asia will pick up again.

Siemens CEO Mr. Loescher said market conditions continue to be too volatile for an IPO of its Osram lighting unit, and it will now most likely spin off Osram to shareholders. Siemens aims to keep a minority stake in Osram, and the move will require shareholder approval at the next annual general meeting in January.

Analysts at Silvia Quandt Research said they expects Siemens to experience difficult quarters ahead, as the business climate seems to be deteriorating more than expected.

At 0916 GMT, Siemens shares traded down 4% at EUR64.61, while Germany's DAX index traded down 1.1%.

-Write to Friedrich Geiger at friedrich.geiger@dowjones.com

Harriet Torry also contributed to this article

Order free Annual Report for Siemens AG

Visit http://djnweurope.ar.wilink.com/?ticker=DE0007236101 or call +44 (0)208 391 6028

Order free Annual Report for BASF SE

Visit http://djnweurope.ar.wilink.com/?ticker=DE000BASF111 or call +44 (0)208 391 6028

Order free Annual Report for BASF SE

Visit http://djnweurope.ar.wilink.com/?ticker=US0552625057 or call +44 (0)208 391 6028

Order free Annual Report for Siemens AG

Visit http://djnweurope.ar.wilink.com/?ticker=US8261975010 or call +44 (0)208 391 6028

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 26, 2012 05:57 ET (09:57 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Vestas får ordre på 51 MW i Kina

15-12-2017 15:38:40
Vindmølleproducenten Vestas har hentet en ordre på 51 megawatt (MW) i Kina, fortæller selskabet i en meddelelse fredag eftermiddag.Der er tale om en bestilling af 23 V110-2,0 MW-møller, der er optimeret til en kapacitet på 2,2 MW hver.Møllerne skal opstilles i Liaoning-provinsen i det nordøstlige Kina.Ordren indeholder også en serviceaftale, fremgår det, men længden af den samt kundens og projekte..

Novo: Lægemiddelkomité anbefaler godkendelse af Ozempic i Europa - NY2

15-12-2017 13:19:21
Novo Nordisk har fået en vigtig anbefaling fra en lægemiddelkomité under de europæiske sundhedsmyndigheder, EMA, der anbefaler GLP-1-håbet Semaglutid godkendt på det europæiske marked.Semaglutid, der skal markedsføres under navnet Ozempic, skal først officielt godkendes af EMA og EU-Kommissionen, før midlet kan ryge på markedet, men en positiv anbefaling fra lægemiddelkomitéen er som oftest også l..

Aktier/middag: H+H til tops mens C20 går i rødt

15-12-2017 11:41:22
Humøret er vrissent på børserne i Europa fredag, og ved middagstid er det danske C20 Cap-indeks ingen undtagelse, da det falder 0,9 pct. til 1121,34 - især trukket ned af Novo Nordisk.Uden for eliteindekset belønnes H+H International dog pænt for et virksomhedsopkøb til 800 mio. kr., der vil løfte selskabets omsætning med en halv milliard.USA SPREDER DÅRLIG STEMNINGDen generelle nedturen følger i ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

ABB Ltd 26,00 0,0% Aktiekurs uændret
ABB Ltd N 25,77 0,0% Aktiekurs uændret
ABB Ltd 221,20 0,0% Aktiekurs uændret
Basf SE Basf SE REG SHS 93,67 0,0% Aktiekurs uændret
Basf N 109,80 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
17. december 2017 13:03:20
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB1 - 2017-12-17 13:03:20 - 2017-12-17 13:03:20 - 1 - Website: OKAY